Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Melatonin in Relapsing-Remitting Multiple Sclerosis Patients

This study has been completed.
Information provided by (Responsible Party):
Tehran University of Medical Sciences Identifier:
First received: January 18, 2011
Last updated: August 12, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)